Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.
2.

To Establish Bethesda System for Diagnosis of Thyroid Nodules on the Basis of Fnac with Histopathological Correlation.

Garg S, Desai NJ, Mehta D, Vaishnav M.

J Clin Diagn Res. 2015 Dec;9(12):EC17-21. doi: 10.7860/JCDR/2015/14823.6897. Epub 2015 Dec 1.

3.

A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?

Straccia P, Rossi ED, Bizzarro T, Brunelli C, Cianfrini F, Damiani D, Fadda G.

Cancer Cytopathol. 2015 Dec;123(12):713-22. doi: 10.1002/cncy.21605. Epub 2015 Sep 10.

4.

Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area.

Lee YB, Cho YY, Jang JY, Kim TH, Jang HW, Chung JH, Oh YL, Kim SW.

Head Neck. 2017 Feb;39(2):269-274. doi: 10.1002/hed.24578. Epub 2016 Sep 12.

PMID:
27617626
5.

Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hospital, with histological correlation.

Mastorakis E, Meristoudis C, Margari N, Pouliakis A, Leventakos K, Chroniaris N, Panayiotides I, Karakitsos P.

Cytopathology. 2014 Apr;25(2):120-8. doi: 10.1111/cyt.12062. Epub 2013 Apr 1.

PMID:
23551656
6.

A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience.

Arul P, Akshatha C, Masilamani S.

Biomed J. 2015 Dec;38(6):517-22. doi: 10.1016/j.bj.2015.08.001. Epub 2016 Mar 9.

7.

Assessment of malignancy rate in thyroid nodules according to the Bethesda system of fine-needle aspiration. Report from a tertiary center in the Southwestern region of Saudi Arabia.

Al-Shraim MM, Kaood OM, Hussein MR, Al-Ahmary AM, Al Shehri GY, Jastania RA, Mahfouz AA, Abu-Eshy SA.

Saudi Med J. 2012 Feb;33(2):167-71.

PMID:
22327757
8.

Thyroid cytopathology reporting by the bethesda system: a two-year prospective study in an academic institution.

Mehra P, Verma AK.

Patholog Res Int. 2015;2015:240505. doi: 10.1155/2015/240505. Epub 2015 Jan 22.

9.

Results of retrospective classification of thyroid FNAs according to the Bethesda system: would this have improved accuracy?

Srbova L, Gabalec F, Ryska A, Cap J.

Cytopathology. 2015 Aug;26(4):231-7. doi: 10.1111/cyt.12171. Epub 2014 Jul 30.

PMID:
25077794
10.

The Use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists.

Kim M, Park HJ, Min HS, Kwon HJ, Jung CK, Chae SW, Yoo HJ, Choi YD, Lee MJ, Kwak JJ, Song DE, Kim DH, Lee HK, Kim JY, Hong SH, Sohn JS, Lee HS, Park SY, Hong SW, Shin MK.

J Pathol Transl Med. 2017 Jul;51(4):410-417. doi: 10.4132/jptm.2017.04.05. Epub 2017 Jun 14.

11.

Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.

Jo VY, Stelow EB, Dustin SM, Hanley KZ.

Am J Clin Pathol. 2010 Sep;134(3):450-6. doi: 10.1309/AJCP5N4MTHPAFXFB.

PMID:
20716802
12.

Reproducibility of 'The Bethesda System for reporting Thyroid Cytopathology': A MultiCenter Study with Review of the Literature.

Bhasin TS, Mannan R, Manjari M, Mehra M, Gill Sekhon AK, Chandey M, Sharma S, Kaur P.

J Clin Diagn Res. 2013 Jun;7(6):1051-4. doi: 10.7860/JCDR/2013/5754.3087. Epub 2013 Jun 1.

13.

The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.

Theoharis CG, Schofield KM, Hammers L, Udelsman R, Chhieng DC.

Thyroid. 2009 Nov;19(11):1215-23. doi: 10.1089/thy.2009.0155.

PMID:
19888859
14.

The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years.

Kiernan CM, Broome JT, Solórzano CC.

Ann Surg Oncol. 2014 Oct;21(11):3522-7. doi: 10.1245/s10434-014-3743-1. Epub 2014 May 6.

15.

Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.

Faquin WC, Wong LQ, Afrogheh AH, Ali SZ, Bishop JA, Bongiovanni M, Pusztaszeri MP, VandenBussche CJ, Gourmaud J, Vaickus LJ, Baloch ZW.

Cancer Cytopathol. 2016 Mar;124(3):181-7. doi: 10.1002/cncy.21631. Epub 2015 Oct 12.

16.

Bethesda System for Reporting Thyroid Cytopathology: A three-year study at a tertiary care referral center in Saudi Arabia.

Al Dawish MA, Robert AA, Muna A, Eyad A, Al Ghamdi A, Al Hajeri K, Thabet MA, Braham R.

World J Clin Oncol. 2017 Apr 10;8(2):151-157. doi: 10.5306/wjco.v8.i2.151.

17.

The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions.

Crowe A, Linder A, Hameed O, Salih C, Roberson J, Gidley J, Eltoum IA.

Cancer Cytopathol. 2011 Oct 25;119(5):315-21. doi: 10.1002/cncy.20174. Epub 2011 Jul 12.

18.

Examining the Bethesda criteria risk stratification of thyroid nodules.

Deniwar A, Hambleton C, Thethi T, Moroz K, Kandil E.

Pathol Res Pract. 2015 May;211(5):345-8. doi: 10.1016/j.prp.2015.02.005. Epub 2015 Feb 27.

PMID:
25796296
20.

Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience in a Rural Setting.

Guo A, Kaminoh Y, Forward T, Schwartz FL, Jenkinson S.

Int J Endocrinol. 2017;2017:9601735. doi: 10.1155/2017/9601735. Epub 2017 Feb 9.

Supplemental Content

Support Center